SMMTNasdaqPharmaceutical Preparations

Summit Therapeutics Inc. (SMMT) earnings date, market-implied expected move, and options open interest by expiry

15.79

+0.99 · +6.72%

post 15.75 −0.28%

Closed19:34 ET

Open14.83Volume6.0MMkt cap$12.6BEPS-1.11

Day14.83 – 16.4158%52-wk12.07 – 29.2321%

SMMT

Summit Therapeutics Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

57dSummit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress
82dCould Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)’s Cancer Drug Partnership Create a New Treatment Standard?

News

Next report

Last report

−8.81%

shaded = implied · ▲▼ = realized

Jul 23 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

+2.41%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

244 managers

Top fund weight

1.01%

SMMT weight · XBI

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Summit Therapeutics (SMMT). No implied move.

Implied vs realized

1 report

—≥ implied

Q2 FY26Jul 23 '26confirmed—▼−8.81%—

quarterimplied−10%0+10%realized×

Q2 FY26—▼−8.81%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 10 expiries · Nov 2 close

2.14OI · 10 expiries · Nov 2 closeP/C open interest · Nov 6 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

5,790+69%Nov 63d2,703+23%

308+14%Nov 1310d0.66465+11%0.66

4,8590%Nov 2017d0.1728,863+30%0.17

3500%Nov 2724d1.14306+1%1.14

1—Dec 431d0.205—0.20

5 later expiries

3+200%Dec 1138d0.2512—0.25

290+1%Dec 1845d0.84

ExpiryPutsCallsP/C

Nov 63d5,790+69%2,703+23%2.14

Nov 1310d308+14%465+11%0.66

Nov 2017d4,8590%28,863+30%0.17

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:30 ET

Intraday

Event sensitivity

PCE ×1.02· ±4.7% vs ±4.6% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±4.7%11 of 19×1.02

FOMCrate decision±3.8%14 of 24×0.83

PPIproducer prices±3.6%4 of 10×0.78

NFPjobs report±2.6%7 of 10×0.56

CPIconsumer prices±2.2%6 of 10×0.48

GDPgross domestic product±2.1%14 of 19×0.46

CPROFcorporate profits±2.0%8 of 12×0.43

Bar = avg |move| to ±5% · tick = ±4.6% avg day · ×base = |move| ÷ ±4.6% · min 6 releases

Earnings history

EPS -0.28 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Jul 23 '26 · confirmed	-0.28	—
Q1 FY26	—	-0.24	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod